GENERICBID

DEAD

Serial Number

86326856

Owner

AUBURN PHARMACEUTICAL COMPANY

Attorney

Robyn S. Lederman

First Use Date

Dec 20, 2014

Filing Date

Jul 2, 2014

Add to watchlist:

No watchlists yet

+ Create New Watchlist

View on USPTO

GENERICBID Trademark

Serial Number: 86326856 • Registration: 4843070

GENERICBID is a trademark filed by AUBURN PHARMACEUTICAL COMPANY on July 2, 2014. The trademark is classified under Class 35 (Advertising & Business). The application is currently no longer active.

Trademark Classes

Class 35 - Advertising & Business

Advertising; business management; business administration; office functions

Owner Contact Info

AUBURN PHARMACEUTICAL COMPANY

Rochester Hills, MI 48309

Entity Type: 03

AUBURN PHARMACEUTICAL, LLC (5 trademarks)

1744 ROCHESTER INDUSTRIAL DR.
ROCHESTER HILLS, MI 48309

Entity Type: 16

Legal Representation

Attorney of Record

Robyn S. Lederman

353 trademarks filed View all →

Correspondence Address

Robyn S. Lederman BROOKS KUSHMAN P.C.

1000 TOWN CTR FL 22

SOUTHFIELD, MI 48075-1238

UNITED STATES

Trademark Details

Filing Date

July 2, 2014

Registration Date

October 27, 2015

First Use Anywhere

December 20, 2014

First Use in Commerce

January 5, 2015

Cancellation Date

May 8, 2026

Goods & Services

Arranging and conducting auctions in the field of PHARMACEUTICALS; On-line auction services; Providing advertising, marketing and promotional services for the pharmaceutical and medical products of others; Providing internet auction services via A WEBSITE AND MOBILE APPLICATIONS

Filing History

CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9

May 8, 2026 CAEX

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

Dec 4, 2024 ASGN

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

Oct 28, 2024 REM2

NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED

Nov 5, 2021 NAS8

REGISTERED - SEC. 8 (6-YR) ACCEPTED

Nov 5, 2021 8.OK

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

Nov 5, 2021 APRE

TEAS SECTION 8 RECEIVED

Jun 25, 2021 ES8R

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

Oct 27, 2020 REM1

REGISTERED-SUPPLEMENTAL REGISTER

Oct 27, 2015 R.SR

LAW OFFICE PUBLICATION REVIEW COMPLETED

Sep 21, 2015 PREV

ASSIGNED TO LIE

Sep 21, 2015 ALIE

NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED

Aug 26, 2015 AAUA

APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER

Aug 25, 2015 CNTA

USE AMENDMENT ACCEPTED

Aug 25, 2015 IUAA

TEAS/EMAIL CORRESPONDENCE ENTERED

Jul 25, 2015 TEME

AMENDMENT TO USE PROCESSING COMPLETE

Jul 25, 2015 AUPC

USE AMENDMENT FILED

Jul 25, 2015 IUAF

CORRESPONDENCE RECEIVED IN LAW OFFICE

Jul 24, 2015 CRFA

TEAS REQUEST FOR RECONSIDERATION RECEIVED

Jul 24, 2015 ERFR

TEAS AMENDMENT OF USE RECEIVED

Jul 24, 2015 EAAU

NOTIFICATION OF FINAL REFUSAL EMAILED

Apr 3, 2015 GNFN

FINAL REFUSAL E-MAILED

Apr 3, 2015 GNFR

FINAL REFUSAL WRITTEN

Apr 3, 2015 CNFR

TEAS/EMAIL CORRESPONDENCE ENTERED

Mar 17, 2015 TEME

CORRESPONDENCE RECEIVED IN LAW OFFICE

Mar 16, 2015 CRFA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Mar 16, 2015 TROA

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Oct 20, 2014 GNRN

NON-FINAL ACTION E-MAILED

Oct 20, 2014 GNRT

NON-FINAL ACTION WRITTEN

Oct 20, 2014 CNRT

PREVIOUS ALLOWANCE COUNT WITHDRAWN

Oct 20, 2014 ZZZX

APPROVED FOR PUB - PRINCIPAL REGISTER

Oct 20, 2014 CNSA

ASSIGNED TO EXAMINER

Oct 11, 2014 DOCK

NOTICE OF PSEUDO MARK E-MAILED

Jul 9, 2014 MPMK

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Jul 8, 2014 NWOS

NEW APPLICATION ENTERED

Jul 5, 2014 NWAP

Related Trademarks

More from this Owner

AUBURN PHARMACEUTICAL

A AUBURN PHARMACEUTICAL

A AUBURN

GENERICBID

More in Same Class

IMPACT GENOME PROJECT

Serial #86326462

PUBPASS

INTERNATIONAL INSTITUTE OF DIAMOND VALUATION

APPLIED GEOSPATIAL ANALYTICS

BÄCKEREI EBERL